Alzheimer's disease apolipoprotein pathology for treatment elucidation and development
Project factsheets
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 22 projects/programmes
Corona accelerated R&D in Europe
European Lead Factory
European Gram-negative Antibacterial Engine
European screening centre; unique library for attractive biology
European Autism Interventions - a Multicentre Study for Developing New Medications
EUbOPEN: Enabling and unlocking biology in the OPEN
Understanding chronic pain and improving its treatment
Inhibiting misfolded protein propagation in neurodegenerative diseases
Kinetics for Drug Discovery
Machine learning ledger orchestration for drug discovery
New Drugs for Bad Bugs
Novel methods leading to new medications in depression and schizophrenia
Modelling neuron-glia networks into a drug discovery platform for pain efficacious treatments
The Open Pharmacological Concepts Triple Store
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools
Molecular basis of the bacterial cell wall permeability
Unrestricted leveraging of targets for research advancement and drug discovery